Foster Dykema Cabot & Partners, LLC Novo Nordisk A S Transaction History
Foster Dykema Cabot & Partners, LLC
- $1.19 Trillion
- Q3 2024
A detailed history of Foster Dykema Cabot & Partners, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Foster Dykema Cabot & Partners, LLC holds 4,388 shares of NVO stock, worth $469,121. This represents 0.04% of its overall portfolio holdings.
Number of Shares
4,388
Previous 3,090
42.01%
Holding current value
$469,121
Previous $441 Million
18.46%
% of portfolio
0.04%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding NVO
# of Institutions
1,955Shares Held
319MCall Options Held
5.32MPut Options Held
5.04M-
Jennison Associates LLC20.2MShares$2.16 Billion1.5% of portfolio
-
Morgan Stanley New York, NY14.6MShares$1.56 Billion0.16% of portfolio
-
Bank Of America Corp Charlotte, NC14.2MShares$1.52 Billion0.18% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.3MShares$1.42 Billion0.65% of portfolio
-
Fayez Sarofim & CO Houston, TX12.6MShares$1.34 Billion4.91% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $241B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...